Articles

Management of cutaneous T & B cell lymphomas: a comprehensive review

BJH - volume 9, issue 3, june 2018

M. de Vicq de Cumptich MD, C. Springael MD, PhD, J. Somja MD, C. Bonnet MD, PhD, P. Heimann MD, PhD, U. Sass MD, A. Janssens MD, PhD, D. Bron MD, PhD

SUMMARY

Primary cutaneous lymphomas are a heterogeneous group of diseases with indolent or aggressive behaviour, skin-limited or systemic extension, from T or B cell origin. The optimal management requires the multi-disciplinary approach with dermatologists, hemato-oncologists, pathologists and molecular biologists. The objective of this review is to harmonise the work-up and the treatment of these different entities of cutaneous T or B cell lymphoma in Belgium, according to the availability of the drugs and specialised treatment such as extracorporeal photopherisis or total skin electron beam therapy.

(BELG J HEMATOL 2018;9(3):86–100)

Read more

PP74 Limited impact of imatinib in a murine model of sclerodermatous chronic graft-versus-host disease

BJH - volume 8, issue Abstract Book BHS, february 2017

G. Fransolet , L. Belle , J. Somja MD, M. Binsfeld , P. Delvenne , P. Drion , M. Hannon , Y. Beguin MD, PhD, G. Ehx , F. Baron MD, PhD

Read more

P22 Case report: Richter syndrome with plasmablastic lymphoma

BJH - volume 8, issue Abstract Book BHS, february 2017

A. Ladang , M. Simul , J. Somja MD, J. Foguenne , A. Gothot MD, PhD, A. Keutgens , F. Tassin

Read more

PP3.1 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease

BJH - volume 7, issue Abstract Book BHS, january 2016

G. Fransolet , G. Ehx , J. Somja MD, L. Delens , M. Hannon , S. Dubois , P. Drion , J. Caers MD, PhD, S. Humblet-Baron , L. Belle , P. Delvenne , Y. Beguin MD, PhD, G. Conteduca , F. Baron MD, PhD

Read more

P3.17 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease

BJH - volume 6, issue Abstract Book BHS, january 2015

G. Fransolet , G. Ehx , J. Somja MD, L. Belle , P-V. Drion , S. Humblet-Baron , Y. Beguin MD, PhD, B. Baron

Read more

P4.10 Imatinib improves survival of chronic Graft-versus-Host disease by inhibiting TGF-beta and PDGF-r pathways in mice

BJH - volume 5, issue Abstract Book BHS, january 2014

G. Fransolet , L. Belle , J. Somja MD, S. Humblet-Baron , S. Dubois , P. Delvenne , Y. Beguin MD, PhD, F. Baron MD, PhD

Read more

O.6 Infusion of CliniMACS® (Miltenyi Biotec) enriched regulatory T-cells delays experimental xenogeneic graft-versus-host disease

BJH - 2013, issue BHS Abstractbook, january 2013

M. Hannon , C. Lechanteur PhD, J. Somja MD, S. Lucas , L. Belle , F. Bruck , E. Baudoux MD, Y. Beguin MD, PhD, S. Humblet-Baron , F. Baron MD, PhD

Read more